摘要
目的:建立一侧肾无功能或缺失、对侧肾功能代偿患者^(99)mTc-DTPA肾动态显像肾小球滤过率(GFR)、高峰时间(t_b)及半排时间(C_(1/2))正常参考值范围。方法:回顾分析115例单侧肾功能正常而对侧肾缺如或无功能检查者的^(99)mTc-DTPA肾动态显像结果,统计其GFR、显像剂摄取t_b及C_(1/2)。同时收集102例健康供肾者作为正常对照。结果:115例留存肾^(99)mTc-DTPA肾动态显像的GFR、t_b、C_(1/2)正常参考值范围分别为(37.19~102.58)m L/min、(2.10~4.23)min、(6.50~21.51)min。无论留存肾是左肾还是右肾,两者的GFR、t_b及C_(1/2)比较差异均无统计学意义(P>0.05)。留存肾GFR较供体肾代偿性增加(t=9.363,P<0.001)。留存肾t_b较供体肾延长(Z=3.595,P<0.001)。青年组、中年组和老年组组间GFR比较差异有统计学意义(F=6.130,P=0.003),青年组和中年组留存肾较供体肾GFR分别增加了47%和37%。结论:建立留存肾功能正常检查者^(99)mTc-DTPA显像GFR、t_b、C_(1/2)等参数的正常值参考范围,能够客观、有效地评价肾小球滤过功能,为临床诊疗提供依据。
Aim: To establish the normal reference range of compensatory residual kidney function parameters using ^(99)mTc-DTPA renal dynamic imaging. Methods: A total of 115 patients with normal unilateral renal function and the contralateral kidney non-function or received nephrectomy,and 102 donors( control group) were collected. Parameters including glomerular filtration rate( GFR),the peak time of nephrogram( tb) and half time of kidney washout( C(1/2)) were collected.Results: The normal reference range of GFR,tb,and C(1/2) in 115 cases of renal ^(99)mTc-DTPA renal dynamic imaging were( 37. 19-102. 58) m L/min,( 2. 10-4. 23) min,( 6. 50-21. 51) min,respectively. There was no significant difference in GFR,tb,and C(1/2) between the residual left and the residual right kidneys( P〈0. 05). GFR of the residual kidneys was statistically higher than that of donor kidneys( t = 9. 363,P〈0. 001). The tbof the residual kidneys was statistically longer than that of normal donor kidneys( Z = 3. 595,P〈0. 001). Compared with control group,GFR of the young group and the middle-aged group increased by 47% and 37%( F = 6. 130,P = 0. 003),respectively. Conclusion: The established normal reference range of GFR,tb,C(1/2) based on ^(99)mTc-DTPA imaging could be impersonality and efficiency to evaluate glomerular filtration function,and provide a basis for clinical diagnosis and treatment.
出处
《郑州大学学报(医学版)》
CAS
北大核心
2018年第1期68-71,共4页
Journal of Zhengzhou University(Medical Sciences)
基金
国家临床重点专科建设项目(国卫办医函[2013]544号)